Quest Diagnostics (DGX) Revenue (2009 - 2026)

Quest Diagnostics has disclosed Revenue across 18 years of filings, most recently posting $2.9 billion for Q1 2026.

• Revenue for Q1 2026 came in at $2.9 billion, up 9.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.3 billion (up 11.03% YoY), and the FY2025 annual result was $11.0 billion, up 11.78% from the prior year.
• Revenue came in at $2.9 billion for Q1 2026 at Quest Diagnostics, up from $2.8 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $2.9 billion in Q1 2026 to a low of $2.3 billion in Q4 2023.
• The 5-year median for Revenue is $2.5 billion (2022), against an average of $2.5 billion.
• Across the five-year window, Revenue retreated 14.98% in 2022 and advanced 15.19% in 2025, its largest moves.
• Quest Diagnostics' Revenue stood at $2.3 billion in 2022, then dropped by 1.93% to $2.3 billion in 2023, then increased by 14.55% to $2.6 billion in 2024, then rose by 7.06% to $2.8 billion in 2025, then climbed by 3.17% to $2.9 billion in 2026.
• The last three Revenue figures came in at $2.9 billion (Q1 2026), $2.8 billion (Q4 2025), and $2.8 billion (Q3 2025), per Business Quant data.